1.Technologies in the treatment of type 1 diabetes
Optimizing treatment by using insulin pumps, continuous glucose monitors and bolus calculators in type 1 diabetes.
2. Development of new algorithms/technologies
Development and test of a dual-hormone closed-loop and open-loop systems for people with type 1 diabetes.
3. Development of guidelines for everyday use of technology in diabetes treatment
How should persons with diabetes bolus insulin and handle glucose values when eating different types of food, using new faster insulins and exercising in new ways.
4. Using data from device downloading at the clinical level
At present different uploading systems are used and data are used only for each consultation but not saved for systematically analysis. Methods will be developed for that purpose.
5. Technologies in the treatment of type 2 diabetes
Will insulin pumps, continuous glucose monitors, bolus calculators and other apps be effective and successful in insulin treated type 2 diabetes at home, in the hospital setting and for better communication with health care providers?
1. StenoTech Study
Aim: To uncover barriers for successful treatment with insulin pumps (+/- CGM) in type 1 diabetes and develop novel personalized intervention tools that addresses these barriers. In a randomized study the newly developed approach will be studied.
Collaborators: Nordsjællands Hospital Hillerød, the SDCC Clinic, the SDCC Health Promotion Center, University of Copenhagen, University of Southern Denmark.
Learn more about the study
2. ABC-Flash Study
Aim: To investigate which tools; carb. counting with the use of a bolus calculator in an app, using Freestyle Libre Flash or both interventions simultaneously are most successful in injection treated type 1 diabetes persons with less optimally glycemic treatment.
Collaborators: The SDCC Clinic, Steno Partner Hospitals: Rigshospitalet, Bispebjerg Frederiksberg, Hillerød og Amager Hvidovre Hospital.
3. Closed-loop dual-hormone studies
Aim: To develop and test our own algorithms for insulin only or dual-hormone closed loop systems. Collaborators: DTU Compute.
4. Open-loop dual-hormone studies
Aim: To get data on glucose excursions in different situations to be used in decision support for glucagon dosage in an open-loop dual-hormone system.
Collaborators: DTU Compute og Zealand Pharma.
Aim: To develop/detect an uploading system which can be used by all available devices and based on this system get useful reports and data collection for person feedback, quality assurance and research. Further data should be available in Epic.
Collaborators: Pediatric departments Herlev and Hillerød Hospital, CIMT and others.
Aim: Development of a communication tool in an application to be used at consultations between persons with type 2 diabetes and health care providers.
Collaborators: An EIT-Health project with DTU, Center for Diabetes and University of Copenhagen.
7. Ward CGM project:
Aim: To study glucose levels in persons with different types of diabetes during hospital admissions for surgery in order to develop an alarm system for health care providers to avoid hypo- and hyperglycemia.
Collaborators: WARD group and the Novo Nordisk Foundation.
Aim: To study efficacy of different technologies as insulin pumps and continuous glucose monitors in type 2 diabetes with non-optimal glucose treatment although treated with insulin and other glucose-lowering drugs.
Collaborators: The SDCC Type 2 Clinic, SDC-centers in Denmark.